Savvy Updates 2/27/24: Medtrum Nano CGM “Not Great”, Autoimmune Diseases Curable?, Sensotrend.com, FDA TAP Program Expanded, Interview with Prof. Lutz Heinemann, Final Week Book Give-Away

Savvy Updates 2/27/24: Medtrum Nano CGM “Not Great”, Autoimmune Diseases Curable?, Sensotrend.com, FDA TAP Program Expanded, Interview with Prof. Lutz Heinemann, Final Week Book Give-Away

Medtrum Nano CGM… A tale of two sensors by Tim Street for Diabettech.com, 20 February 2024. Recently, Medtrum introduced the Nano, which has to vie for the title of “Smallest CGM currently available”. It has a very small form factor. Its first release, earlier in 2023...
Savvy Update 2/19/24: DiaMyd FDA Fast Track for Immunotherapy, Eversense E3 CGM Gets Expanded Medicare Coverage, Few More FREE Give-a-Way Books, Casting Call for Alerting but Untrained Pets

Savvy Update 2/19/24: DiaMyd FDA Fast Track for Immunotherapy, Eversense E3 CGM Gets Expanded Medicare Coverage, Few More FREE Give-a-Way Books, Casting Call for Alerting but Untrained Pets

Immunotherapy to treat people with type 1 diabetes genotype granted fast track designation by Jill Rollet for Healio.com/endocrinology, 16 February 2024. The FDA granted fast track designation for an immunotherapy to treat type 1 diabetes among people with the human...
Savvy Updates 2/12/24:  Insulet Wins CE Mark for O5 & Abbott Libre, Sinocare iCAN i3 CGM, Sync CGMs w/SmartWatch, Salmon’s New Compounds for Heart Health, D & Aging & Muscle Loss, “How Low is Too Low” Video with TCOYD, A Few More Books Left, Benefits/Risks of Pumps & Closed-Loop Systems, Valentine’s Day Carb List

Savvy Updates 2/12/24: Insulet Wins CE Mark for O5 & Abbott Libre, Sinocare iCAN i3 CGM, Sync CGMs w/SmartWatch, Salmon’s New Compounds for Heart Health, D & Aging & Muscle Loss, “How Low is Too Low” Video with TCOYD, A Few More Books Left, Benefits/Risks of Pumps & Closed-Loop Systems, Valentine’s Day Carb List

Insulet wins CE mark for integration of insulin pump with Abbott CGM by Nick Paul Taylor for MedTechDive.com, 8 February 2024. Since the launch of the Omnipod 5 in 2022, Insulet has worked to integrate the pump with devices from Abbott, Dexcom’s main competitor for...
Savvy Update 2/5/24:  Lilly, Novo Trillion $ Stocks, Pancreas Can Regenerate, Indigo CGM/CMM, Non-sugar Sweeteners Alter Gut, Medicare Drug Price Negotiations Begin, Think Like a Pancreas Podcast, FREE GIVEAWAY!!!

Savvy Update 2/5/24: Lilly, Novo Trillion $ Stocks, Pancreas Can Regenerate, Indigo CGM/CMM, Non-sugar Sweeteners Alter Gut, Medicare Drug Price Negotiations Begin, Think Like a Pancreas Podcast, FREE GIVEAWAY!!!

Lilly, Novo could be first trillion-dollar health stocks: world’s largest sovereign wealth fund by Dulan Lokuwithana for SeekAlpha.com, 31 January 2024. Weight loss drugmakers Eli Lilly and Novo Nordisk could be the first healthcare stocks to achieve the $1T...
Savvy Updates 1/29/24: Modular Medical Submits to FDA, Insulin Nano Carriers, Know Labs at ATTD, Samsung & Non-Invasive CGM, PBMs HUGE Spending Increase, (video) Microbiome & T1D, T1D & Arthritis, Insulin Pumps & Pregnancy

Savvy Updates 1/29/24: Modular Medical Submits to FDA, Insulin Nano Carriers, Know Labs at ATTD, Samsung & Non-Invasive CGM, PBMs HUGE Spending Increase, (video) Microbiome & T1D, T1D & Arthritis, Insulin Pumps & Pregnancy

Modular Medical submits next-gen insulin pump for FDA clearance by Sean Whooley for DrugDeliveryBusiness.com, 19 January 2024. Modular Medical announced it submitted its next-generation MODD1 insulin pump to the FDA for 510(k) clearance. San Diego-based Modular...
Savvy Updates 1/22/24: embecta Patch Pump Submits to FDA, Apple Redesigns Smart Watch, SiBionics GCM Not Accurate Enough, Dr. Jeremy Pettus/Microdosing w/Glucagon, SERIOUS DKA Advice, CMS Changes Rules on Prior Authorization, Fruit Bats & New T1D Treatments

Savvy Updates 1/22/24: embecta Patch Pump Submits to FDA, Apple Redesigns Smart Watch, SiBionics GCM Not Accurate Enough, Dr. Jeremy Pettus/Microdosing w/Glucagon, SERIOUS DKA Advice, CMS Changes Rules on Prior Authorization, Fruit Bats & New T1D Treatments

embecta Announces FDA 510(k) Submission for Insulin Patch Pump announced by Embecta, 9 January 2024. Embecta Corp., a global diabetes care company with a 100-year legacy in insulin delivery, announced that it has submitted a 510(k) premarket filing to the U.S. Food...
Skip to content